The size of the global cell culture market was evaluated at US$ 25.4 billion in 2022 and will be worth US$ 29.0 billion in 2023. Additionally, due to rising demand for biopharmaceuticals like vaccines and stem cells as well as increased R&D efforts, the global cell culture market is anticipated to grow at an astounding CAGR of 11.8% between 2023 and 2033, surpassing a valuation of roughly US$ 88.6 billion by that year.
The cell culture market is a rapidly growing sector in the life sciences industry that plays a crucial role in various research, drug development, and biotechnology applications. Cell culture refers to the process of growing and maintaining cells in a controlled environment outside of their natural setting. These cultured cells provide valuable insights into cell behavior, disease mechanisms, and therapeutic responses, making them indispensable tools for scientists and researchers.
Request a Sample copy of this Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14318
The cell culture market growth is primarily driven by the increasing demand for biopharmaceutical products and the need for personalized medicine. As the prevalence of chronic diseases rises, pharmaceutical companies are investing heavily in cell culture technologies to develop novel therapies and improve existing ones. Additionally, the expansion of regenerative medicine and tissue engineering applications has further fueled the demand for advanced cell culture techniques.
Technological advancements and innovative solutions are also propelling the market forward. Researchers are continuously developing improved culture media, bioreactors, and 3D cell culture systems to mimic the in vivo conditions more accurately. These developments enhance cell viability, productivity, and overall efficiency, meeting the growing requirements of the biotechnology and pharmaceutical sectors.
Moreover, the increasing focus on stem cell research and the potential of cell-based therapies are contributing significantly to the market’s growth. Stem cells hold immense promise for treating various degenerative disorders and repairing damaged tissues. As a result, both academic and commercial organizations are investing extensively in stem cell research and its applications.
As per FMI, the key market drivers during the forecast period are:
- Acceleration in the pace of research and development activities aiding mass production of biopharmaceuticals
- Rising demand for advanced cell culture-based products
- Wide utility across pharmaceutical companies, research institutes, and food development
- Chronic diseases that warrant innovations in biopharmaceuticals
- Rising consumer demand for monoclonal antibodies (mAbs)
Get The Information You Need By Connecting With Our Analyst Today! https://www.futuremarketinsights.com/ask-question/rep-gb-14318
Cell Culture Application in Pharma & Health is Key to Market Growth:
At the moment, innovations are fueling market expansion. The need for sophisticated versions of cell culture products is growing as a result of significant investments made by various end-user groups in this area. Similar to how biosimilars have a favourable impact on market prospects, there is a rising need for innovative therapies.
All of these elements have worked together to carve out a specific application for cell culture in the pharmaceutical and healthcare industries. This is mostly brought on by the steady increase in cardiovascular, renal, and cancer disorders. Cell culture can open up lucrative opportunities for the pharmaceutical and healthcare industries to flourish as consumer demand for cutting-edge treatment solutions rises.
Key Takeaways from the Report:
- Between 2017 and 2022, the market recorded a CAGR of 13.5%, attaining a valuation of US$ 25.4 billion by 2022.
- During the forecast period, the United States market is projected to expand at a CAGR of 11.6% and reach a valuation of US$ 31.4 billion by 2033.
- Between 2023 and 2033, the United Kingdom market is expected to record a CAGR of 10.9%, to attain a valuation of US$ 3.7 billion by 2033.
- The consumables segment is projected to register a CAGR of 11.4% during the forecast period.
- The biopharmaceutical production segment is anticipated to witness a CAGR of 11.1% during the forecast period.
Unleashing the Potential of Personalization: Our Customization Report Guides You! https://www.futuremarketinsights.com/customization-available/rep-gb-14318
Key Market Developments:
- In January 2022, Cytiva (Danaher Corporation) announced its collaboration with Nucleus Biologics. This can be an important step towards developing custom culture media for cell as well as gene therapies.
- In February 2022, KromaTiD enhanced its services by venturing into cell and blood culture isolation, and processing, coupled with quality control services
Key Players:
- Danaher Corporation
- Thermo Fisher Scientific
- Becton
- Dickinson and Company
- Corning Incorporated
- Merck KgaA
- PromoCell GmbH
- Sartorius AG
Key Segments:
By Product:
- Consumables
- Sera
- Media
- Reagents
- Vessels
- Accessories
- Equipment
- Supporting Equipment
- Bioreactors
- Storage Equipment
By Application:
- Biopharmaceutical Production
- Monoclonal antibodies
- Vaccines production
- Other therapeutic proteins
- Diagnostics
- Drug Screening & Development
- Tissue Engineering & Regenerative Medicine
- Cell and gene therapy
- Drug Screening & Development
- Others
By End User:
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic Laboratories
- Research & Academic Institutes
- Others
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- The Middle East and Africa (MEA)
Get Ahead with Detailed Market Intelligence: Discount Now to Access! https://www.futuremarketinsights.com/checkout/14318
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube